← DSP Mutual Fund

DSP Nifty Healthcare Index Fund - Direct- Growth

Index/ETF Data as of Apr 2026 Comparing Mar 2026 → Apr 2026
Share: WhatsApp X
Stocks Held
20
Apr 2026
Equity Holdings
₹18.48 Cr
Equity only, excl. debt & cash
Top 5 Weight
50.2%
High concentration
Top 10 Weight
76.3%
High concentration
Changes
20
0 new · 0 exits
Top Sector
Pharmaceuticals & Biotechnology
78.7% of portfolio
📋 What Happened This Month Among existing holdings, Fortis Healthcare Limited saw the biggest increase — now at 4.76% of the portfolio. Sun Pharmaceutical Industries Limited was trimmed the most, now at 18.94%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 78.7%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Feb 2026 Mar 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 78.0% 78.8% +0.8%
Healthcare Services 21.8% 20.4% -1.4%
Mar 2026 Apr 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 78.8% 78.7% -0.1%
Healthcare Services 20.4% 20.7% +0.3%
Biggest Add
Fortis Healthcare Limited
+0.47% · now 4.76%
Biggest Trim
Sun Pharmaceutical Industries Limited
-0.35% · now 18.94%

What Changed?

Comparing Mar 2026 → Apr 2026

Mar 2026 Apr 2026
↑ 10 Increased ↓ 10 Decreased
#StockSectorMar 2026Apr 2026Change
1
Fortis Healthcare Limited
₹88.46 L
Healthcare Services 4.29% 4.76% +0.47%
2
Divi's Laboratories Limited
₹1.52 Cr
Pharmaceuticals & Biotechnology 7.83% 8.18% +0.35%
3
Glenmark Pharmaceuticals Limited
₹66.63 L
Pharmaceuticals & Biotechnology 3.33% 3.58% +0.25%
4
Laurus Labs Limited
₹78.78 L
Pharmaceuticals & Biotechnology 4.00% 4.24% +0.24%
5
Mankind Pharma Limited
₹46.75 L
Pharmaceuticals & Biotechnology 2.35% 2.52% +0.17%
6
Cipla Limited
₹1.36 Cr
Pharmaceuticals & Biotechnology 7.14% 7.29% +0.15%
7
Piramal Pharma Limited
₹18.45 L
Pharmaceuticals & Biotechnology 0.88% 0.99% +0.11%
8
Syngene International Limited
₹16.32 L
Healthcare Services 0.77% 0.88% +0.11%
9
Aurobindo Pharma Limited
₹71.43 L
Pharmaceuticals & Biotechnology 3.78% 3.84% +0.06%
10
Dr. Reddy's Laboratories Limited
₹1.48 Cr
Pharmaceuticals & Biotechnology 7.93% 7.98% +0.05%
#StockSectorMar 2026Apr 2026Change
1
Sun Pharmaceutical Industries Limited
₹3.52 Cr
Pharmaceuticals & Biotechnology 19.29% 18.94% -0.35%
2
Lupin Limited
₹1.03 Cr
Pharmaceuticals & Biotechnology 5.82% 5.53% -0.29%
3
Torrent Pharmaceuticals Limited
₹80.52 L
Pharmaceuticals & Biotechnology 4.57% 4.33% -0.24%
4
IPCA Laboratories Limited
₹39.11 L
Pharmaceuticals & Biotechnology 2.31% 2.10% -0.21%
5
Apollo Hospitals Enterprise Limited
₹1.45 Cr
Healthcare Services 7.91% 7.78% -0.13%
6
Biocon Limited
₹47.20 L
Pharmaceuticals & Biotechnology 2.67% 2.54% -0.13%
7
Max Healthcare Institute Limited
₹1.36 Cr
Healthcare Services 7.42% 7.31% -0.11%
8
Alkem Laboratories Limited
₹58.16 L
Pharmaceuticals & Biotechnology 3.22% 3.13% -0.09%
9
Abbott India Limited
₹24.42 L
Pharmaceuticals & Biotechnology 1.40% 1.31% -0.09%
10
Zydus Lifesciences Limited
₹41.04 L
Pharmaceuticals & Biotechnology 2.26% 2.21% -0.05%

Full Portfolio

20 stocks — Apr 2026

# Stock Sector Cap Weight & Value
1
₹3.52 Cr
Pharmaceuticals & Biotechnology
18.94%
2
₹1.52 Cr
Pharmaceuticals & Biotechnology
8.18%
3
₹1.48 Cr
Pharmaceuticals & Biotechnology
7.98%
4
₹1.45 Cr
Healthcare Services
7.78%
5
₹1.36 Cr
Healthcare Services
7.31%
6
₹1.36 Cr
Pharmaceuticals & Biotechnology
7.29%
7
₹1.03 Cr
Pharmaceuticals & Biotechnology
5.53%
8
₹88.46 L
Healthcare Services
4.76%
9
₹80.52 L
Pharmaceuticals & Biotechnology
4.33%
10
₹78.78 L
Pharmaceuticals & Biotechnology
4.24%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 DSP Mutual Fund — Portfolio & Holdings
See all funds managed by DSP Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.